BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,926,170 | +9.2% | 51,038 | +31.9% | 0.01% | +16.7% |
| Q2 2023 | $1,763,162 | +0.9% | 38,700 | -10.2% | 0.01% | -14.3% |
| Q1 2023 | $1,748,024 | -32.4% | 43,097 | -15.1% | 0.01% | -36.4% |
| Q4 2022 | $2,586,575 | -8.9% | 50,747 | -3.7% | 0.01% | -15.4% |
| Q3 2022 | $2,839,000 | -14.3% | 52,712 | +2.2% | 0.01% | -13.3% |
| Q2 2022 | $3,312,000 | -18.0% | 51,558 | -1.0% | 0.02% | +7.1% |
| Q1 2022 | $4,040,000 | -56.5% | 52,101 | -51.9% | 0.01% | -51.7% |
| Q4 2021 | $9,296,000 | -40.5% | 108,295 | -44.2% | 0.03% | -45.3% |
| Q3 2021 | $15,614,000 | +273.6% | 194,127 | +273.9% | 0.05% | +278.6% |
| Q2 2021 | $4,179,000 | -19.2% | 51,918 | -15.3% | 0.01% | -26.3% |
| Q1 2021 | $5,169,000 | -12.7% | 61,292 | -16.9% | 0.02% | -13.6% |
| Q4 2020 | $5,920,000 | -3.6% | 73,782 | -3.4% | 0.02% | -15.4% |
| Q3 2020 | $6,140,000 | -2.1% | 76,352 | +4.8% | 0.03% | -13.3% |
| Q2 2020 | $6,271,000 | +42.1% | 72,833 | +34.0% | 0.03% | +7.1% |
| Q1 2020 | $4,412,000 | -1.2% | 54,337 | +1.7% | 0.03% | +21.7% |
| Q4 2019 | $4,467,000 | -3.7% | 53,425 | +0.8% | 0.02% | -14.8% |
| Q3 2019 | $4,637,000 | -38.3% | 53,011 | -42.3% | 0.03% | -37.2% |
| Q2 2019 | $7,518,000 | -42.1% | 91,797 | -42.5% | 0.04% | -45.6% |
| Q1 2019 | $12,982,000 | +12.9% | 159,656 | -8.6% | 0.08% | -6.0% |
| Q4 2018 | $11,496,000 | -18.5% | 174,655 | -4.6% | 0.08% | -2.3% |
| Q3 2018 | $14,112,000 | +5.7% | 183,056 | +1.3% | 0.09% | -5.5% |
| Q2 2018 | $13,349,000 | +23.5% | 180,783 | +8.8% | 0.09% | +19.7% |
| Q1 2018 | $10,808,000 | +161.6% | 166,176 | +159.9% | 0.08% | +171.4% |
| Q4 2017 | $4,132,000 | +4.8% | 63,927 | +1.7% | 0.03% | -6.7% |
| Q3 2017 | $3,943,000 | +0.8% | 62,831 | -2.7% | 0.03% | +3.4% |
| Q2 2017 | $3,911,000 | +25.0% | 64,603 | +5.2% | 0.03% | +16.0% |
| Q1 2017 | $3,129,000 | +70.6% | 61,408 | +48.4% | 0.02% | +56.2% |
| Q4 2016 | $1,834,000 | -0.8% | 41,369 | +6.5% | 0.02% | 0.0% |
| Q3 2016 | $1,849,000 | +37.7% | 38,846 | +30.8% | 0.02% | +23.1% |
| Q2 2016 | $1,343,000 | -13.3% | 29,696 | -21.2% | 0.01% | -13.3% |
| Q1 2016 | $1,549,000 | +13.9% | 37,705 | +5.7% | 0.02% | +15.4% |
| Q4 2015 | $1,360,000 | +0.3% | 35,672 | -13.6% | 0.01% | +8.3% |
| Q3 2015 | $1,356,000 | -52.6% | 41,308 | +1.0% | 0.01% | +200.0% |
| Q2 2015 | $2,860,000 | -1.0% | 40,900 | -3.0% | 0.00% | 0.0% |
| Q1 2015 | $2,889,000 | +11.7% | 42,184 | +19.4% | 0.00% | 0.0% |
| Q4 2014 | $2,587,000 | +2.5% | 35,317 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $2,525,000 | -1.9% | 35,189 | -1.1% | 0.00% | 0.0% |
| Q2 2014 | $2,574,000 | -0.8% | 35,598 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $2,596,000 | +1.6% | 35,283 | -3.9% | 0.00% | 0.0% |
| Q4 2013 | $2,554,000 | +16.7% | 36,729 | +10.2% | 0.00% | 0.0% |
| Q3 2013 | $2,189,000 | -6.2% | 33,338 | -1.0% | 0.00% | -20.0% |
| Q2 2013 | $2,333,000 | – | 33,681 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |